Efgartigimod as Rescue Therapy for PD-1 Inhibitor-Associated Myasthenia Gravis, Myocarditis, and Myositis (MMM) Syndrome: A 2-Case Report and Literature Review. [PDF]
Liu ZH +7 more
europepmc +1 more source
Progress in the Treatment of Refractory Myasthenia Gravis. [PDF]
Liu D, Mao J, Song J, Wang M.
europepmc +1 more source
A multi-component prime-boost vaccination regimen with a consensus MOMP antigen enhances Chlamydia trachomatis clearance [PDF]
Badamchi-Zadeh, A +9 more
core +1 more source
Molecular engineering approaches to half-life extension of therapeutic biomolecules. [PDF]
Wang Y, Chang J, Liu J.
europepmc +1 more source
Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier, and distribution to tumor cells in HER2+ brain metastasis model systems. [PDF]
Khan I +9 more
europepmc +1 more source
Albumin Levels Are Predictive of Cachexia-Induced Time-Dependent Clearance of Therapeutic Antibodies: A Physiologically Based Pharmacokinetic Model of Durvalumab. [PDF]
Proctor JR, Wong H.
europepmc +1 more source
Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties [PDF]
Jeffrey L Nordstrom +14 more
core +1 more source
Advances in the treatment of autoimmune nodopathy: based on treatment strategies of CIDP. [PDF]
Pang ZD, Sun H, Wei XJ, Nie CP, Yu XF.
europepmc +1 more source

